BUILDING STRATIFIED BIOMIMETIC TISSUES AND ORGANS USING CROSSLINKED ULTRASHORT PEPTIDE HYDROGEL MEMBRANES
    12.
    发明申请
    BUILDING STRATIFIED BIOMIMETIC TISSUES AND ORGANS USING CROSSLINKED ULTRASHORT PEPTIDE HYDROGEL MEMBRANES 有权
    使用交联超声波水凝胶膜构建分层生物组织和机构

    公开(公告)号:US20150320908A1

    公开(公告)日:2015-11-12

    申请号:US14639035

    申请日:2015-03-04

    Abstract: The present invention relates to hydrogel membranes comprising a hydrogel, said hydrogel comprising a plurality of tetramer amphiphilic peptides and/or peptoids capable of self-assembling into three-dimensional macromolecular nanofibrous networks, which entrap water and form said hydrogels, wherein at least a portion of said plurality of tetramer amphiphilic peptides and/or peptoids is chemically cross-linked. The present invention further relates to stratisfied biostructures and devices comprising at least two hydrogel membranes of the invention, which can be used e.g. to rebuild human skin and for tissue engineering of organs and tissues. The present invention further relates to corneal implants and devices comprising a hydrogel membrane of the invention.

    Abstract translation: 本发明涉及包含水凝胶的水凝胶膜,所述水凝胶包括能够自组装成三维大分子纳米纤维网络的多个四聚体两亲肽和/或拟肽,其捕获水并形成所述水凝胶,其中至少一部分 的所述多个四聚体两亲肽和/或拟肽化学交联。 本发明还涉及包含本发明的至少两种水凝胶膜的粘合生物结构和装置,其可以例如使用。 重建人体皮肤和器官和组织的组织工程。 本发明还涉及角膜植入物和包含本发明的水凝胶膜的装置。

    Ultrashort peptides as exogenous second harmonic probes for bioimaging applications

    公开(公告)号:US10105454B2

    公开(公告)日:2018-10-23

    申请号:US15324144

    申请日:2015-07-08

    Abstract: Various aspects of the present invention relate to a peptide based biomaterial for visualization by SHG microscopy. In particular the invention relates to the use of short peptides as a non-linear optical (NLO) material for second harmonic generation (SHG) microscopy. A preferred short peptide comprises LIVAGK (LK6) and contains a non-polar aliphatic tail (with decreasing hydrophobicity) and a polar head; and can self-assemble into hydrogels; wherein which the peptide forms a tunable fibrous structure for in vitro and in vivo imaging applications and is suitable in disease diagnostics such as amyloidosis, including 1) neuro-degenerative amyloidosis, e.g. Alzheimer's (AD), Parkinson's, Huntington's (PD), 2) non-neuropathic localized amyloidosis such as in Type II Diabetes, and 3) systemic amyloidosis that occurs in multiple tissues, e.g. cataracts and lattice corneal dystrophy (LCD), as well as drug delivery and/or wound dressings.

Patent Agency Ranking